Patent · US Active

Method for treating glaucoma

US9339514B2 · kind B2 · utility

29Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 9, 2014
Grant dateMay 17, 2016
Priority date
Expiry dateApr 9, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of treating glaucoma or other eye disease in a patient is provided. The method includes injecting an eye of the patient with a cohesive monophasic gel containing cross-linked hyaluronic acid or its salt. The injection can be under the scleral flap and/or conjunctiva of the eye, thereby creating and maintaining a conjunctival bleb, and/or the injection can be in the supra-scleral and/or supra-choroidal (sub-scleral) space of the eye thereby reducing the intraocular pressure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.